Uterine Hemorrhage: Clinical Trials

60 trials for Uterine Hemorrhage, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

36 completed, 11 unknown, 4 recruiting, 4 withdrawn. 60 Phase 2, 13 Phase 1, 8 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 260Completed 36, Unknown 11, Recruiting 4, Withdrawn 4, Terminated 3, Not yet recruiting 2
Phase 113Completed 5, Unknown 5, Terminated 2, Withdrawn 1
Phase 38Completed 8

Follow Uterine Hemorrhage: new trials by email Literature Review of Uterine Hemorrhage trials Research Report on Uterine Hemorrhage

Trials (filtered) newest first · largest first

All 60 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
HMBeacon: A Phase 2 Study to Evaluate ALN-6400 in Adult and Adolescent Female Patients With VWD and HMB
ALN-6400 - Von Willebrand Disease (VWD), Heavy Menstrual Bleeding (HMB)
Phase 2RecruitingAlnylam Pharmaceuticals242026-07-302026-10-26
Sublingual Oxytocin for the Prevention of Post-partum Hemorrhage
Oxytocin sublingual, Oxytocin IM - Post Partum Hemorrhage
Phase 2Not yet recruitingInsud Pharma3302026-05-302026-04-23
Role of Intravenous Calcium to Decrease Blood Loss During Intrapartum Cesarean Section
Calcium Chloride, Placebo - Post Partum Haemorrhage, Cesarean Section Surgery
Phase 2Not yet recruitingPak Emirates Military Hospital1822026-05-012026-04-24
Transdermal Ethinyl Estradiol and Norelgestromin for Irregular Bleeding in Contraceptive Implant Users
Transdermal Ethinyl Estradiol/Norelgestromin Patch, Placebo Patch - Menstruation Disturbances, Metrorrhagia
Phase 2RecruitingChulalongkorn University402025-07-292025-12-10
Oxytocin Pharmacokinetics and Pharmacodynamics
deuterated oxytocin (d5OT) - Post Partum Hemorrhage, Cesarean Section Complications
Phase 2RecruitingStanford University1002025-01-012026-08-21
High Or Low Dose pOstpartUm Oxytocin at the Time of Cesarean Birth
Oxytocin - Postpartum Hemorrhage, Pregnancy Complications
Phase 2WithdrawnUniversity of Chicago2024-10-012024-12-10
D-chiro-inositol and AUB
D-chiro-inositol and lactalbumin (high dose), D-chiro-inositol and lactalbumin (low dose) - Abnormal Uterine Bleeding
Phase 2UnknownUniversity Of Perugia202024-06-012024-05-03
PAI-1, tPA, TFPI and HEECs in Uterine Hemostasis
Sample Collection and Endometrial Biopsy - Menstrual Bleeding, Heavy
Phase 1 / Phase 2UnknownOregon Health and Science University702023-07-122024-08-19
Efficacy of Carbetocin in Prevention of Postpartum Hemorrhage in Obese Versus Non Obese Women
Carbetocin 100 Microgram/mL Solution for Injection - Obesity, Maternal, Post Partum Hemorrhage
Phase 1 / Phase 2CompletedCairo University1502023-07-062024-01-22
Prevention of Postpartum Hemorrhage With Tranexamic Acid
Tranexamic acid, No intervention - Post Partum Hemorrhage
Phase 2RecruitingInova Health Care Services1202022-12-282026-10-16
Failed Endometrial Ablation Treatment With Implantable Progesterone (FEAT) Study
Etonogestrel 68mg implant - Abnormal Uterine Bleeding, Dysmenorrhea
Phase 2WithdrawnSaskatchewan Health Authority - Regina Area2022-07-012025-11-25
Effect of Tranexamic Acid and Calcium Dobesilate for Bleeding of Endometrial Origin
Tranexamic Acid, Calcium dobesilate (Doxium) - Heavy. Mentrual Bleeding, Abormal utèrine Bleeding
Phase 2 / Phase 3CompletedDistrict Headquarters Teaching Hospital Sahiwal1002022-01-012024-11-27
Prevention of Primary Postpartum Haemorrhage
Misoprostol, Oxytocin - Primary, Post Partum Hemorrhage
Phase 2UnknownIslamabad Medical and Dental College1802021-02-032021-02-25
A Program to Evaluate Riastap® and FIBTEM® for the Early Control and Treatment of Postpartum Hemorrhage (PERFECT PPH)
fibrinogen concentrate, Placebo - Postpartum Hemorrhage
Phase 1 / Phase 2WithdrawnYale University2021-01-012021-03-15
Chinese Medicine Periodic Therapy for Dysfunctional Uterine Bleeding During Adolescence With Yin Deficiency and Blood Heat Syndrome
Kidney-tonifying and tune up Chong-Ren hemostasis Chinese medicine, Gong Xue Ning capsules - Dysfunctional Uterine Bleeding
Phase 2CompletedChildren's Hospital of Fudan University1602020-09-022022-08-03
Tranexamic Acid Versus Sublingual Misoprostol in Reducing Blood Loss During Elective CS in High Risk Cases
Misoprostol, Tranexamic acid, Oxytocin - Post Partum Hemorrhage
Phase 2CompletedCairo University3452020-01-202025-07-28
Tranexamic Acid for the Prevention of Postpartum Haemorrhage
Tranexamic Acid 100 milligram/Milliliter, Oxytocin - Postpartum Hemorrhage
Phase 1 / Phase 2UnknownBenha University602020-01-012021-01-13
Tranexamic Acid for Prevention of Hemorrhage in Cesarean Delivery
Tranexamic Acid, Placebo - Post Partum Hemorrhage, Fibrinolysis; Hemorrhage
Phase 2 / Phase 3CompletedUniversity of Texas Southwestern Medical Center1102019-06-172021-01-19
Intrauterine Misoprostol Versus Rectal Misoprostol in Reducing Blood Loss During Cesarean Section
Misoprostol - Hemorrhage, Postpartum
Phase 2UnknownCairo University982018-11-152020-03-18
Use of TXA to Prevent Postpartum Hemorrhage
TXA (1g), Placebo (0.9% saline) - Post Partum Hemorrhage
Phase 2UnknownSunnybrook Health Sciences Centre312018-03-062022-09-13

Showing 20 of 60. Sign in to see all of them.

Narrower conditions

Postpartum Hemorrhage (34)  ·  Menorrhagia (11)  ·  Metrorrhagia (9)  ·  Hemorrhage (6)  ·  Leiomyoma (4)  ·  Menstruation Disturbances (2)  ·  Pain (2)  ·  Thrombosis (2)  ·  von Willebrand Diseases (2)  ·  Adenomyosis (1)  ·  Agranulocytosis (1)  ·  Amenorrhea (1)  ·  Anemia (1)  ·  Anemia, Aplastic (1)

Broader conditions

Female Urogenital Diseases and Pregnancy Complications (60)  ·  Pathologic Processes (60)  ·  Pathological Conditions, Signs and Symptoms (60)  ·  Urogenital Diseases (60)  ·  Hemorrhage (54)  ·  Obstetric Labor Complications (34)  ·  Puerperal Disorders (34)  ·  Pregnancy Complications (33)  ·  Female Urogenital Diseases (26)  ·  Genital Diseases (26)  ·  Genital Diseases, Female (26)  ·  Uterine Diseases (26)  ·  Menstruation Disturbances (12)  ·  Hematologic Diseases (5)

Interventions

Misoprostol (11)  ·  Tranexamic Acid (10)  ·  Oxytocin (9)  ·  Norethindrone Acetate (3)  ·  Sodium Chloride (3)  ·  Estradiol (2)  ·  Ethinyl Estradiol (2)  ·  Fibrinogen (2)  ·  Saline Solution (2)  ·  carbetocin (2)  ·  elagolix (2)  ·  estradiol, norethindrone drug combination (2)  ·  Anastrozole (1)  ·  Arthotec (1)  ·  Calcium Chloride (1)

Sponsors

Ain Shams University (4)  ·  Ain Shams Maternity Hospital (3)  ·  Cairo University (3)  ·  Assiut University (2)  ·  Bayer (2)  ·  Benha University (2)  ·  Chulalongkorn University (2)  ·  McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc. (2)  ·  Qazvin University Of Medical Sciences (2)  ·  AbbVie (1)  ·  AbbVie (prior sponsor, Abbott) (1)  ·  Aga Khan University (1)  ·  Ahmed Alanwar (1)  ·  Alnylam Pharmaceuticals (1)  ·  AstraZeneca (1)

Countries

Egypt (14)  ·  United States (12)  ·  Iran (4)  ·  Pakistan (4)  ·  United Kingdom (4)  ·  Italy (3)  ·  Canada (2)  ·  Germany (2)  ·  Netherlands (2)  ·  Sweden (2)  ·  Thailand (2)  ·  Austria (1)  ·  Bangladesh (1)  ·  Belgium (1)  ·  Bulgaria (1)

Top investigators

Abubaker M Elnashar, MD (1)  ·  Adel S Helal, MD (1)  ·  Amgad E. Abou-Gamrah, Ass.Prof. (1)  ·  Aminur Rahman, MBBS,MSc (1)  ·  Amr Yehia, MD, MRCOG (1)  ·  Anna Palatnik, MD (1)  ·  Anne J. Wikkelsoe, MD (1)  ·  Arash Afshari, MD (1)  ·  Ariana Kh. Jawad, Assistant professor (1)  ·  Ashish Premkumar, MD, PhD (1)

Results publications

PMID 10467792, PMID 10908457, PMID 11502292, PMID 12466350, PMID 14600674, PMID 15932834, PMID 15950671, PMID 15954876, PMID 16581405, PMID 16842791, PMID 17197859, PMID 17634155, PMID 19432563, PMID 19943825, PMID 20009308, PMID 21833452, PMID 22540529, PMID 22805300, PMID 22882240, PMID 24220703, PMID 25586727, PMID 25588784, PMID 26181091, PMID 27733082, PMID 28707488, PMID 29025850, PMID 29524595, PMID 30303923, PMID 31022078, PMID 31598047, PMID 32559602, PMID 32609374, PMID 33064852, PMID 33248975, PMID 33384016, PMID 33705565, PMID 34218053, PMID 34858760, PMID 35038612, PMID 36934142, PMID 37626292

NIH funding

2009 (1), 2014 (1), 2025 (1), K23HL141640 (1), KL2TR001877 (1), R01HD110109 (1), UL1TR001876 (1)